Rho has the experience in Phase III clinical trial management needed to provide accurate and efficient efficacy results
Rho offers a broad range of services that allows us to provide capacity needed for phase III clinical trial management.
Clinical operations provides experience and leadership at each site
The value of Rho's Clinical Operations lies in the experience we bring to the client. As a result, we can provide strong site management and enrollment strategies. We consider the Lead Clinical Research Associate (LCRA) to be an integral part of the study—that’s why ours have an average of 5 to 10 years of clinical operations leadership experience. Our CRAs develop expertise within therapeutic areas, become more closely integrated with the rest of the project team, and focus on a smaller number of protocols.
Medical monitoring services with a focus on safety
Medical monitoring plays an important role in providing protection to research subjects, integrity of results, and consistency of protocol. Our team of Medical Monitors is composed of an on-board staff and network of specialist physicians that guide study teams through the issues faced in clinical research studies.
Robust statistical services and advice
We critically review Phase II results, investigate data accuracy, and conduct power analyses when designing larger Phase III studies. Our statisticians support data and safety monitoring boards (DSMBs) and conduct interim analyses. Because timing is so critical in phase III, our counsel can help you make timely and informed decisions about sample sizes and doses and get you the efficacy data you need to move forward to submission.
Clinical data management capacity
Phase III studies require strong capabilities to handle a large volume of sites, subjects, and case report forms (eCRFs or CRFs). Rho delivers the clinical data management capacity necessary in phase III clinical trials. We've demonstrated this strength in successfully completed projects with hundreds of sites and thousands of subjects.
Discover Rho's expertise in Phase III trials
Our phase II and III capabilities include: